Navigation Links
Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:6/5/2010

CHICAGO, June 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of six studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including an evaluation of biological similarities and differences between stage II and III colon cancer, suggesting a potential role for the Oncotype DX® colon cancer test in patients with stage III disease, pending further study. The company also announced the first presentation of results from its collaboration with Pfizer Oncology for assessing prognosis for early-stage renal cell carcinoma.

"With our innovative clinical collaborations and access to numerous landmark trials, we have the opportunity to advance the quality of cancer treatment decisions as evidenced by the six studies being presented at ASCO," said Steven Shak, M.D., chief medical officer of Genomic Health.  "Collectively these results reflect our efforts to continue adding value to the Oncotype DX breast and colon cancer tests, while advancing our broad and deep product pipeline aimed at optimizing treatment decisions in multiple tumor types."

Potential Role for Oncotype DX Colon Cancer Test in Stage III Disease

An evaluation of biological similarities and differences between stage II and III colon cancer suggests that the Oncotype DX colon cancer Recurrence Score®, currently available for treatment planning in stage II colon cancer, may also predict recurrence risk in stage III colon cancer. The study, "Comparison of molecular and pathologic features of stage II and stage III colon cancer in 4 large studies conducted for development of
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
2. Mount Sinai Medical Center Drives Genomic Research Collaboration with Isilon Scale-out NAS
3. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
4. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
5. Trinean Reduces Volume and Time Requirements for Genomic DNA Quantification
6. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
7. Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
8. The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB)
9. Institute for Systems Biology uses Complete Genomics genome sequencing service to verify gene responsible for Miller syndrome
10. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
11. Melanoma transcriptome reveals novel genomic alterations not seen before
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... N.Y. (PRWEB) August 21, 2014 The ... the first private college in the Mid-Hudson Region to ... will now begin accepting applications from qualified “high-technology” businesses ... “We are very pleased to have been selected for ... Governor Cuomo’s transformative initiative to stimulate economic development in ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that the ... and Mexico currently faces ... approved agents, the anticipated label extension of Boehringer ... of emerging biologics will substantially increase the competitiveness ... IL-5 inhibitors will introduce a new dynamic to the ...
(Date:8/21/2014)... 21, 2014 Mathematic studies at the Program ... and funded by the Jeffrey Epstein VI Foundation , ... be visually identified for elimination. These aggressive cells are the ... shows a topological map of what to look for when ... for while tumor cells can be extracted from biopsy, it,s ...
(Date:8/21/2014)... 21, 2014 OTC Markets Group ... a biotechnology company, on its approval to list ... on OTCQX®, the best marketplace for established U.S. ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... execution of its growth strategy and achievement of ...
Breaking Biology Technology:The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2
... , COLLEGEVILLE, Pa., Aug. 11 ... WYE ), announced it received notice that the action date for ... Biologics License Application (BLA) for Prevnar ... from September 30, 2009, to December 30, 2009. In response ...
... , , WILMINGTON, Del., Aug. 11 ... appropriate use of drugs, is sponsoring a free Webinar-on-Demand created ... as a role of chief safety officers in healthcare companies. ... at ParagonRx,s website, www.para g onrx.com/experience/webinars/ ...
... Baltimore Convention Center - September 21-23, 2009 ... This summit will attract more than 1,200 experts from more than ... than 100 speakers, including governors, federal officials, and top researchers and ... and human-interest stories. This is your chance to meet and ...
Cached Biology Technology:Wyeth Provides Regulatory Update on Prevnar 13* in the United States 2Wyeth Provides Regulatory Update on Prevnar 13* in the United States 3Wyeth Provides Regulatory Update on Prevnar 13* in the United States 4Wyeth Provides Regulatory Update on Prevnar 13* in the United States 5Wyeth Provides Regulatory Update on Prevnar 13* in the United States 6World Stem Cell Summit to Be Held in Baltimore 2
(Date:8/21/2014)... 2014 , WHERE: , San Diego Convention ... 92101 , WHAT: , Invited and platform ... research in human genetics. Examples of sessions include: ... rare genetic variants in health and disease, the ... sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , Crowdsourced ...
(Date:8/21/2014)... published in the journal Carcinogenesis by researchers ... for the protein adenomatous polyposis coli (APC) in suppressing ... in the U.S. , Lead author Kristi Neufeld, associate ... of the Cancer Biology program at the KU Cancer ... trying to understand the various activities of APC, a ...
(Date:8/21/2014)... international standards process, will be available soon and will ... published in the OnlineFirst version of Nutrition in ... of the American Society for Parenteral and Enteral Nutrition ... of misconnection that can be harmful and even fatal ... join medical devices, components, and accessories to deliver fluids ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3New feeding tube connectors will improve patient safety 2
... report presents a 20-year road map for increasing U.S. resilience ... highly populated area. The report was mostly written prior ... of experts who authored it noted that the Japanese experience ... in a country acknowledged as a leader in implementing earthquake-resilience ...
... Good news for candy and chocolate lovers: they tend ... waist circumferences, and have decreased levels of risk factors for ... study(1) published in Nutrition Research . The findings ... RD, Louisiana State University Agricultural Center, cautions it is all ...
... A new series of events at the New ... solid waste that may offer large cities sustainable alternatives ... in the "Trash Talk" series on Thursday, April 7, ... and biological treatment. Experts will explain how ...
Cached Biology News:US earthquake resilience needs strengthening, says new report 2US earthquake resilience needs strengthening, says new report 3New study shows you can have your candy and eat it too -- without adverse health effects 2
Antibody Purification Specificity: Antibody Purification ...
... Alkaline Phosphatase Conjugation ... Fluorescein Isothiocyanate Conjugation R. Phycoerythrin Conjugation ... Alexa Fluor 488 Conjugation Alexa Fluor ... Rpe-Alexa Fluor 750 Conjugation Apc-Alexa ...
Qa-1 (6A8.6F10)...
Human Cell Line Slides...
Biology Products: